Related Experiment Videos
Inhibitory effect of recombinant TGF alpha-PE40 on vascular smooth muscle cell proliferation
1Department of Cardiology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Aim:
To study inhibitory effect of recombinant transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TP40) on proliferation of the cultured vascular smooth muscle cells (SMC).
Methods:
Expression of epidermal growth factor receptor (EGFR) mRNA and EGFR in cultured proliferating and quiescent SMC was analyzed with Northern blot and immunohistochemistry. Inhibitory effects of TP40 on SMC proliferation and protein synthesis were analyzed with crystal violet staining and [3H]leucine incorporation. Competition assays were performed by the addition of 100-fold excess of EGF.
Results:
Expression of EGFR mRNA and EGFR in rapidly proliferating SMC increased than that in quiescent SMC. When the concentration of TP40 was 10 or 100 micrograms.L-1, inhibitory effects of TP40 on rapidly proliferating SMC proliferation and protein synthesis were much higher than that on quiescent SMC (P < 0.01), and the IC50 of [3H]leucine incorporation against rapidly proliferating and quiescent SMC were 8.01 (5.05-12.69) and 121.95 (90.98-163.47) micrograms.L-1. Excess EGF completely blocked inhibitory effects of TP40.
Conclusion:
The rapidly proliferating SMC express EGFR at a high level. TP40 selectively inhibited the proliferation of rapidly proliferating SMC. The cytotoxic effects of TP40 were specifically mediated by EGFR.
Insights
Recombinant transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TP40) selectively inhibits vascular smooth muscle cell proliferation by targeting epidermal growth factor receptors (EGFR). This targeted approach offers potential for therapeutic applications in vascular diseases.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Vascular smooth muscle cells (SMC) play a critical role in vascular health and disease.
- Understanding the regulation of SMC proliferation is crucial for developing targeted therapies.
- Epidermal growth factor receptor (EGFR) is implicated in cellular growth and proliferation.
Purpose of the Study:
- To investigate the inhibitory effect of a novel fusion protein, TP40, on cultured vascular smooth muscle cell proliferation.
- To determine if TP40's effects are mediated through EGFR signaling.
Main Methods:
- Analysis of EGFR mRNA and protein expression in proliferating and quiescent SMC using Northern blot and immunohistochemistry.
- Assessment of TP40's impact on SMC proliferation and protein synthesis via crystal violet staining and [3H]leucine incorporation.
- Competition assays with epidermal growth factor (EGF) to confirm receptor specificity.
Main Results:
- EGFR expression was significantly higher in rapidly proliferating SMC compared to quiescent SMC.
- TP40 demonstrated potent inhibition of proliferation and protein synthesis in rapidly proliferating SMC, with significantly lower IC50 values.
- Excess EGF effectively blocked the inhibitory effects of TP40, confirming EGFR-mediated action.
Conclusions:
- Rapidly proliferating vascular smooth muscle cells exhibit elevated levels of EGFR.
- TP40 selectively targets and inhibits the proliferation of rapidly proliferating SMC.
- The cytotoxic effects of TP40 are specifically mediated through the epidermal growth factor receptor.